I'd like to know the reason, Dew, why you have not taken a position in ARIA. You seem to follow the thread, and the story.
Is it valuation? Is it the fact that Ponatinib results are still 12-15 months away (at least)? Do you not like what you see with the Ridaforolimus compound? There's got to be a reason. I'm just wondering what it is...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.